Advertisement
Screener

Medtronic plc (MDT) Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments

Medtronic plc Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments

Medtronic plc (MDT) reported Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments of $30.00 million for the 3-month period ending 2021-07-30, per its 10-Q filed 2021-09-02.

Discontinued › Income Statement › Other Income

us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments · last filed 2021-09-02

  • Medtronic plc gain (loss) on foreign currency derivative instruments not designated as hedging instruments for the quarter ending 2021-07-30 was $30.00M.
  • Medtronic plc gain (loss) on foreign currency derivative instruments not designated as hedging instruments for the quarter ending 2021-04-30 was -$48.00M, a 148.00% decline year-over-year.
  • Medtronic plc gain (loss) on foreign currency derivative instruments not designated as hedging instruments for the quarter ending 2021-01-29 was -$21.00M, a 240.00% decline year-over-year.
  • Medtronic plc gain (loss) on foreign currency derivative instruments not designated as hedging instruments for the quarter ending 2020-10-30 was $3.00M, a 72.73% decline year-over-year.
  • Medtronic plc gain (loss) on foreign currency derivative instruments not designated as hedging instruments for fiscal 2021 was -$166.00M, a 231.75% decline from fiscal 2020.
  • Medtronic plc gain (loss) on foreign currency derivative instruments not designated as hedging instruments for fiscal 2020 was $126.00M, a 46.61% decline from fiscal 2019.
  • Medtronic plc gain (loss) on foreign currency derivative instruments not designated as hedging instruments for fiscal 2019 was $236.00M.
  • Medtronic plc gain (loss) on foreign currency derivative instruments not designated as hedging instruments for fiscal 2018 was -$226.00M.
Period endGain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments 3 monthGain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments 6 monthGain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments 9 monthGain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments 12 month
2021-07-30$30.00M
10-Q · filed 2021-09-02
-$18.00M
derived: sum of 2 quarters · filed 2021-09-02
-$39.00M
derived: sum of 3 quarters · filed 2021-09-02
-$36.00M
derived: sum of 4 quarters · filed 2021-09-02
2021-04-30-$48.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-25
-$69.00M
derived: sum of 2 quarters · filed 2021-06-25
-$66.00M
derived: sum of 3 quarters · filed 2021-06-25
-$166.00M
10-K · filed 2021-06-25
2021-01-29-$21.00M
10-Q · filed 2021-03-05
-$18.00M
derived: sum of 2 quarters · filed 2021-03-05
-$118.00M
10-Q · filed 2021-03-05
-$18.00M
derived: sum of 4 quarters · filed 2021-09-02
2020-10-30$3.00M
10-Q · filed 2020-12-03
-$97.00M
10-Q · filed 2020-12-03
$3.00M
derived: sum of 3 quarters · filed 2021-09-02
$18.00M
derived: sum of 4 quarters · filed 2021-09-02
2020-07-31-$100.00M
10-Q · filed 2021-09-02
$0.00
derived: sum of 2 quarters · filed 2021-09-02
$15.00M
derived: sum of 3 quarters · filed 2021-09-02
$26.00M
derived: sum of 4 quarters · filed 2021-09-02
2020-04-24$100.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-25
$115.00M
derived: sum of 2 quarters · filed 2021-06-25
$126.00M
derived: sum of 3 quarters · filed 2021-06-25
$126.00M
10-K · filed 2021-06-25
2020-01-24$15.00M
10-Q · filed 2021-03-05
$26.00M
derived: sum of 2 quarters · filed 2021-03-05
$26.00M
10-Q · filed 2021-03-05
$90.00M
derived: sum of 4 quarters · filed 2021-06-25
2019-10-25$11.00M
10-Q · filed 2020-12-03
$10.00M
10-Q · filed 2020-12-03
$75.00M
derived: sum of 3 quarters · filed 2021-06-25
$45.00M
derived: sum of 4 quarters · filed 2021-06-25
2019-07-26-$1.00M
10-Q · filed 2020-09-03
$64.00M
derived: sum of 2 quarters · filed 2021-06-25
$34.00M
derived: sum of 3 quarters · filed 2021-06-25
$94.00M
derived: sum of 4 quarters · filed 2021-06-25
2019-04-26$65.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-25
$35.00M
derived: sum of 2 quarters · filed 2021-06-25
$95.00M
derived: sum of 3 quarters · filed 2021-06-25
$236.00M
10-K · filed 2021-06-25
2019-01-25-$30.00M
10-Q · filed 2020-02-28
$30.00M
derived: sum of 2 quarters · filed 2020-02-28
$171.00M
10-Q · filed 2020-02-28
$225.00M
derived: sum of 4 quarters · filed 2020-06-19
2018-10-26$60.00M
10-Q · filed 2019-12-03
$201.00M
10-Q · filed 2019-12-03
$255.00M
derived: sum of 3 quarters · filed 2020-06-19
$97.00M
derived: sum of 4 quarters · filed 2020-06-19
2018-07-27$141.00M
10-Q · filed 2019-08-30
$195.00M
derived: sum of 2 quarters · filed 2020-06-19
$37.00M
derived: sum of 3 quarters · filed 2020-06-19
$4.00M
derived: sum of 4 quarters · filed 2020-06-19
2018-04-27$54.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-19
-$104.00M
derived: sum of 2 quarters · filed 2020-06-19
-$137.00M
derived: sum of 3 quarters · filed 2020-06-19
-$226.00M
10-K · filed 2020-06-19
2018-01-26-$158.00M
10-Q · filed 2019-03-01
-$191.00M
derived: sum of 2 quarters · filed 2019-03-01
-$280.00M
10-Q · filed 2019-03-01
2017-10-27-$33.00M
10-Q · filed 2018-11-29
-$122.00M
10-Q · filed 2018-11-29
2017-07-28-$25.00M
10-Q · filed 2018-08-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
Integer Holdings Corp (ITGR)United States$4.289B25.17
LivaNova PLC (LIVN)$4.158B24.01
TransMedics Group, Inc. (TMDX)United States$2.911B15.17
Axogen, Inc. (AXGN)United States$2.329B-73.83
BIOLIFE SOLUTIONS INC (BLFS)United States$1.887B23.80
CONMED Corp (CNMD)United States$1.353B26.72
Ceribell, Inc. (CBLL)United States$0.916B-11.27
CapsoVision, Inc (CV)United States$0.310B-12.68
Electromed, Inc. (ELMD)United States$0.233B31.13
EDAP TMS SA (FOCL)$0.171B